Promising data on pediatric relapsed/refractory acute lymphoblastic leukemia to be presented.
Hematology
Latest News
Advertisement
CME Content
Advertisement
Collaboration will examine potential opportunities for combining daratumumab and carfilzomib for the treatment of cancer.
CD98 molecule could be a potential therapeutic target in AML.
The companies plan to collaborate on clinical trials of a novel combination therapy for multiple myeloma.
Rituximab is a cancer medication that can be used in combination with methotrexate to treat symptoms of adult rheumatoid arthritis.
The FDA has accepted the biologics license application from Genentech for a subcutaneous formulation of rituximab for multiple blood cancer indications.
Top news of the week in oncology and cancer drug development.
Developed countries may be able to assist developing countries in ensuring their drugs are safe.
Xgeva targets the RANK ligand pathways to prevent the creation, function, and survival of osteoclasts.
Amgen announces top-line results from trial evaluating Xgeva in multiple myeloma.
Top news of the week in oncology and cancer drug development.
Researchers found a low-cost approach to examine individual cancer cells, which could lead to a breakthrough in treatments.
Top news of the week in oncology and cancer drug development.
Celgene and Agios will collaborate with a technology company to improve diagnostics for patients with acute myeloid leukemia.
Top news of the day from across the health care landscape.
Patients with memory dysfunctions or depression may be less likely maintain adherence to oral oncoltyics.
Top news of the week from The American Journal of Pharmacy Benefits.
Top news of the week in oncology, and cancer drug development.
Top news of the week in oncology, and cancer drug development.
Top news of the day from across the health care landscape.
Top news of the day from across the healthcare landscape.
Top news of the week in cancer research.
Whether or not cancer cells remain in a cancer patient while undergoing treatment may effect multiple myeloma survival.
DHODH inhibitor caused a reduction in leukemic stem cells and long-term remission in mice.
Pevonedistat shows potential to stop melanoma and other types of cancer.
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
FDA Alleges Association Between Prenatal Acetaminophen Use and Autism in Children
2
FDA Initiates Approval of Leucovorin for Patients With Cerebral Folate Deficiency
3
Rapid CAR T Expansion Linked to Delayed Neurotoxicity in Patients Treated With Cilta-Cel
4
Pneumococcal 21-Valent Vaccine Well-Tolerated, Immunogenic in Patients Living With HIV
5
